Microglia retard dengue virus-induced acute viral encephalitis

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Tsai, Tsung Ting ^a   Chen, Chia Ling ^b   Lin, Yee Shin ^c,d   Chang, Chih Peng ^c,d   Tsai, Cheng Chieh ^e   Cheng, Yi Lin ^c   Huang, Chao Ching ^a,c   Ho, Chien Jung ^c   Lee, Yi Chao ^b   Lin, Liang Tzung ^a,f   Jhan, Ming Kai ^a,f   Lin, Chiou Feng ^a,d,f  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^e CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

AEDES; ANIMAL; ANTIGEN PRESENTATION; CD8+ T LYMPHOCYTE; CELL CULTURE; CELL LINE; COMPLICATION; CYTOLOGY; CYTOTOXIC T LYMPHOCYTE; DENGUE; DENGUE VIRUS; GENETICS; HAMSTER; HIPPOCAMPUS; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; MICROGLIA; MOUSE; PATHOGENICITY; PHYSIOLOGY; VIROLOGY; VIRUS ENCEPHALITIS; VIRUS REPLICATION;

AEDES; ANIMALS; ANTIGEN PRESENTATION; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CELLS, CULTURED; CRICETINAE; CYTOKINES; DENGUE; DENGUE VIRUS; ENCEPHALITIS, VIRAL; HIPPOCAMPUS; MICE; MICE, INBRED ICR; MICROGLIA; T-LYMPHOCYTES, CYTOTOXIC; VIRUS REPLICATION;

EID: 84973855962     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep27670     Document Type: Article

References (50)

1. Bhatt, S. et al. The global distribution and burden of dengue. Nature 496, 504-507 (2013).
2. Lee, I. K., Liu, J. W. & Yang, K. D. Fatal dengue hemorrhagic fever in adults: emphasizing the evolutionary pre-fatal clinical and laboratory manifestations. PLoS Negl Trop Dis 6, e1532 (2012).
3. Figueiredo, M. A. et al. Allergies and diabetes as risk factors for dengue hemorrhagic fever: results of a case control study. PLoS Negl Trop Dis 4, e699 (2010).
4. Rothman, A. L. Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol 11, 532-543 (2011).
5. Diamond, M. S. & Pierson, T. C. Molecular Insight into Dengue Virus Pathogenesis and Its Implications for Disease Control. Cell 162, 488-492 (2015).
6. Halstead, S. B. & Cohen, S. N. Dengue Hemorrhagic Fever at 60 Years: Early Evolution of Concepts of Causation and Treatment. Microbiol Mol Biol Rev 79, 281-291 (2015).
7. World Health Organization, Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control, World Health Organization, Geneva, Switzerland, New edition (2009).
8. Cam, B. V., Fonsmark, L., Hue, N. B., Phuong, N. T., Poulsen, A. & Heegaard, E. D. Prospective case-control study of encephalopathy in children with dengue hemorrhagic fever. Am J Trop Med Hyg 65, 848-851 (2001).
9. Garcia-Rivera, E. J. & Rigau-Perez, J. G. Encephalitis and dengue. Lancet 360, 261 (2002).
10. Solomon, T. et al. Neurological manifestations of dengue infection. Lancet 355, 1053-1059 (2000).
11. Carod-Artal, F. J., Wichmann, O., Farrar, J. & Gascon, J. Neurological complications of dengue virus infection. Lancet Neurol 12, 906-919 (2013).
12. Pancharoen, C. & Thisyakorn, U. Neurological manifestations in dengue patients. Southeast Asian J Trop Med Public Health 32, 341-345 (2001).
13. Amaral, D. C. et al. Intracerebral infection with dengue-3 virus induces meningoencephalitis and behavioral changes that precede lethality in mice. J Neuroinflammation 8, 23 (2011).
14. Velandia-Romero, M. L., Acosta-Losada, O. & Castellanos, J. E. In vivo infection by a neuroinvasive neurovirulent dengue virus. J Neurovirol 18, 374-387 (2012).
15. Ramos, C. et al. Dengue virus in the brain of a fatal case of hemorrhagic dengue fever. J Neurovirol 4, 465-468 (1998).
16. Bhatt, R. S., Kothari, S. T., Gohil, D. J., D'Souza, M. & Chowdhary, A. S. Novel evidence of microglial immune response in impairment of Dengue infection of CNS. Immunobiology 220, 1170-1176 (2015).
17. Fink, K., Ng, C., Nkenfou, C., Vasudevan, S. G., van Rooijen, N. & Schul, W. Depletion of macrophages in mice results in higher dengue virus titers and highlights the role of macrophages for virus control. Eur J Immunol 39, 2809-2821 (2009).
18. Perry, V. H. & Holmes, C. Microglial priming in neurodegenerative disease. Nat Rev Neurol 10, 217-224 (2014).
19. Das Sarma, J. Microglia-mediated neuroinflammation is an amplifier of virus-induced neuropathology. J Neurovirol 20, 122-136 (2014).
20. Shresta, S., Sharar, K. L., Prigozhin, D. M., Beatty, P. R. & Harris, E. Murine model for dengue virus-induced lethal disease with increased vascular permeability. J Virol 80, 10208-10217 (2006).
21. Sarathy, V. V. et al. A lethal murine infection model for dengue virus 3 in AG129 mice deficient in type I and II interferon receptors leads to systemic disease. J Virol 89, 1254-1266 (2015).
22. de Miranda, A. S. et al. Dengue-3 encephalitis promotes anxiety-like behavior in mice. Behav Brain Res 230, 237-242 (2012).
23. Chaturvedi, U. C., Dhawan, R., Khanna, M. & Mathur, A. Breakdown of the blood-brain barrier during dengue virus infection of mice. J Gen Virol 72 (Pt 4), 859-866 (1991).
24. Thongtan, T. et al. Characterization of putative Japanese encephalitis virus receptor molecules on microglial cells. J Med Virol 84, 615-623 (2012).
25. Faustino, J. V. et al. Microglial cells contribute to endogenous brain defenses after acute neonatal focal stroke. J Neurosci 31, 12992-13001 (2011).
26. Oliveira, E. R. et al. Peripheral effects induced in BALB/c mice infected with DENV by the intracerebral route. Virology 489, 95-107 (2015).
27. Amorim, J. H. et al. Antibodies are not required to a protective immune response against dengue virus elicited in a mouse encephalitis model. Virology 487, 41-49 (2016).
28. Herz, J., Johnson, K. R. & McGavern, D. B. Therapeutic antiviral T cells noncytopathically clear persistently infected microglia after conversion into antigen-presenting cells. J Exp Med 212, 1153-1169 (2015).
29. Kagi, D., Ledermann, B., Burki, K., Zinkernagel, R. M. & Hengartner, H. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu Rev Immunol 14, 207-232 (1996).
30. Cruz-Oliveira, C., Freire, J. M., Conceicao, T. M., Higa, L. M., Castanho, M. A. & Da Poian, A. T. Receptors and routes of dengue virus entry into the host cells. FEMS Microbiol Rev 39, 155-170 (2015).
31. Kyle, J. L., Beatty, P. R. & Harris, E. Dengue virus infects macrophages and dendritic cells in a mouse model of infection. J Infect Dis 195, 1808-1817 (2007).
32. Ghoshal, A. et al. Proinflammatory mediators released by activated microglia induces neuronal death in Japanese encephalitis. Glia 55, 483-496 (2007).
33. Flipse, J. et al. Dengue tropism for macrophages and dendritic cells: the host cell effect. J Gen Virol, doi: 10.1099 (2016).
34. Prestwood, T. R. et al. Gamma interferon (IFN-gamma) receptor restricts systemic dengue virus replication and prevents paralysis in IFN-alpha/beta receptor-deficient mice. J Virol 86, 12561-12570 (2012).
35. Mathew, A., Kurane, I., Rothman, A. L., Zeng, L. L., Brinton, M. A. & Ennis, F. A. Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a. J Clin Invest 98, 1684-1691 (1996).
36. Ho, L. J. et al. Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J Immunol 166, 1499-1506 (2001).
37. Olagnier, D. et al. Cellular oxidative stress response controls the antiviral and apoptotic programs in dengue virus-infected dendritic cells. PLoS Pathog 10, e1004566 (2014).
38. Lambert, C. et al. Dendritic cell differentiation signals induce anti-inflammatory properties in human adult microglia. J Immunol 181, 8288-8297 (2008).
39. Kankirawatana, P., Chokephaibulkit, K., Puthavathana, P., Yoksan, S., Apintanapong, S. & Pongthapisit, V. Dengue infection presenting with central nervous system manifestation. J Child Neurol 15, 544-547 (2000).
40. John, C. C., Carabin, H., Montano, S. M., Bangirana, P., Zunt, J. R. & Peterson, P. K. Global research priorities for infections that affect the nervous system. Nature 527, S178-186 (2015).
41. Row, D., Weinstein, P. & Murray-Smith, S. Dengue fever with encephalopathy in Australia. Am J Trop Med Hyg 54, 253-255 (1996).
42. Despres, P., Frenkiel, M. P., Ceccaldi, P. E., Duarte Dos Santos, C. & Deubel, V. Apoptosis in the mouse central nervous system in response to infection with mouse-neurovirulent dengue viruses. J Virol 72, 823-829 (1998).
43. Tsai, T. T. et al. Antibody-dependent enhancement infection facilitates dengue virus-regulated signaling of IL-10 production in monocytes. PLoS Negl Trop Dis 8, e3320 (2014).
44. Zhang, S. L., Tan, H. C., Hanson, B. J. & Ooi, E. E. A simple method for Alexa Fluor dye labelling of dengue virus. J Virol Methods 167, 172-177 (2010).
45. Lee, Y. R. et al. Suckling mice were used to detect infectious dengue-2 viruses by intracerebral injection of the full-length RNA transcript. Intervirology 48, 161-166 (2005).
46. Lee, Y. R. et al. Dengue virus infection induces autophagy: an in vivo study. J Biomed Sci 20, 65 (2013).
47. Hsing, C. H. et al. Anesthetic propofol causes glycogen synthase kinase-3beta-regulated lysosomal/mitochondrial apoptosis in macrophages. Anesthesiology 116, 868-881 (2012).
48. Svedin, P., Hagberg, H., Savman, K., Zhu, C. & Mallard, C. Matrix metalloproteinase-9 gene knock-out protects the immature brain after cerebral hypoxia-ischemia. J Neurosci 27, 1511-1518 (2007).
49. Chiu, W. H. et al. Vinca alkaloids cause aberrant ROS-mediated JNK activation, Mcl-1 downregulation, DNA damage, mitochondrial dysfunction, and apoptosis in lung adenocarcinoma cells. Biochem Pharmacol 83, 1159-1171 (2012).
50. Wong, P. & Pamer, E. G. Cutting edge: antigen-independent CD8 T cell proliferation. J Immunol 166, 5864-5868 (2001).